Chatbot can analyse health-care imagery, such as PDFs of test results, to accurately diagnose a range of medical conditions.

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

Despite the rising buzz around artificial intelligence, only 31% of Indians have used a generative AI tool, according to a new study by Google and Kantar. The nationwide survey, which covered over ...

These drugs affect genes which play key roles in ... are some of the concerning side effects users may face. A new study has highlighted the mental health risks associated with GLP-1 receptor ...

The drug had already been shown to have anti-tumor potential when treating several other cancers, but this the first time it’s been tested for Merkel Cell Carcinoma. The study was published in the ...

Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs ...

shows that women are much more aware of knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and tirzepatide). The study is by Nadja Auerbach, Voy*, London ...

who has examined the effects of carbamazepine and the antianxiety drug clonazepam on zebra fish, said Brand’s study and her own research indicate pharmaceutical pollution is altering ecosystems ...

Tirzepatide helps people keep off the kilos for 3 years A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it off for at least ...

We’ve done the extensive research all the way from cell-based studies to human data, so we’re now at the point where we have a made a strong case for moving ahead with clinical trials ...

A new study has highlighted the growing global threat of antimicrobial ... The silent pandemic is a phenomenon where drugs stop responding to microbials like bacteria, virus or fungi which were ...

Experts have welcomed this potential alternative, especially for patients wary of injections and drug-resistant variants of the disease. With no new antibiotic being developed, Dr Gilada (not attached ...